Corporate ActionJul 23, 2026, 04:07 PM
AEON Biopharma Raises $1.5M from Over-Allotment Option Exercise
AI Summary
AEON Biopharma announced that on July 23, 2026, the underwriters partially exercised their over-allotment option from a public offering completed on July 15, 2026. This exercise involved the sale of 4,696,102 shares of the company's Class A common stock. The transaction generated additional gross proceeds of approximately $1.5 million, leading to net proceeds of about $1.4 million after deducting underwriting discounts. The over-allotment option for milestone warrants, covering 6,403,290 shares, had been fully exercised previously.
Key Highlights
- Underwriters partially exercised over-allotment option for common stock.
- Sold 4,696,102 shares of Class A common stock.
- Generated additional gross proceeds of approximately $1.5 million.
- Resulted in net proceeds of approximately $1.4 million.
- Previously, over-allotment for milestone warrants (6,403,290 shares) was fully exercised.
- Public offering completed on July 15, 2026.
Price Impact
More from AEON